Hemodynamic management of patients with cardiogenic shock centers on vasopressors, inotropes, and mechanical circulatory devices. With respect to inotropic medications, there is little data to guide optimal management and selection of agents. In this podcast we discuss the results of a recent trial that compared milrinone with dobutamine for patients with cardiogenic shock. Which agent was the winner?
You can get CME credit for this episode hereClick here for CME Account Creation Instructions
Current international guidelines recommend TTM for adult patients with ROSC from OHCA who remain comatose or unable to follow verbal commands. However, the overall...
Patients with severe aortic stenosis who present with acute decompensated heart failure are among the most challenging patients to resuscitate. In this podcast, we...
Currently, there is no approved treatment or proven therapy for COVID-19. As such, many have turned to treatments with little to no supporting evidence....